Peter L. Seraphin, DO

Gastroenterology in Hinsdale, IL

12 Salt Creek Ln, Suite 425, Hinsdale, IL 60521 · Hinsdale Gastroenterology Associates, Sc
NPI 1831204734 Accepts Medicare assignment Offers telehealth 26 years since graduation Public record — not managed by the clinician

About Dr. Peter Seraphin

Dr. Peter Seraphin is a physician specializing in gastroenterology practicing in Hinsdale, IL, a graduate of Arizona College of Osteopathic Medicine Mid Western University (2000). Affiliated with The University of Chicago Medical Center, Uchicago Medicine Adventhealth Bolingbrook, Uchicago Medicine Adventhealth Hinsdale and 1 more. Treated 787 Medicare patients in 2024.

SpecialtyGastroenterologyOther gastroenterology doctors in Hinsdale
CredentialsDO
EducationArizona College of Osteopathic Medicine Mid Western University, 2000CMS Doctors and Clinicians
GenderMale
NPI number1831204734National Provider Identifier (CMS NPPES), issued August 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Where Dr. Peter Seraphin practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Peter Seraphin's specialties and state licenses

Specialty (NPPES)License
Gastroenterology PrimaryIL 036107633

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Peter Seraphin

  • The University of Chicago Medical CenterHospital · Chicago, IL
  • Uchicago Medicine Adventhealth BolingbrookHospital · Bolingbrook, IL
  • Uchicago Medicine Adventhealth HinsdaleHospital · Hinsdale, IL
  • Uchicago Medicine Adventhealth la GrangeHospital · La Grange, IL

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Peter Seraphin's Medicare patients and services (2024)

787Medicare patients
1,373services billed
74average patient age
52%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Removal of polyps or growths of large bowel using an endoscope with mechanical snare261$258.87
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more228$130.99
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes216$79.60
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope132$87.64
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes93$132.02
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more81$172.59
Colorectal cancer screening; colonoscopy on individual at high risk76$184.79
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope51$84.79

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis49%
  • Ischemic heart disease38%
  • Chronic kidney disease28%
  • Diabetes27%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Peter Seraphin's Medicare quality score (MIPS 2024)

84.2/100final MIPS score
67.7quality
99promoting interoperability
40improvement activities
80.6cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Peter Seraphin (2025)

$762.55 in 37 general payments reported in 2025.

TypePaymentsAmount
Food and beverage37$762.55

Paying companies: AbbVie Inc. ($232.09), Takeda Pharmaceuticals U.S.A., Inc. ($99.47), Ardelyx, Inc. ($65.32), Janssen Biotech, Inc. ($62.26), Gilead Sciences, Inc. ($57.23), Salix Pharmaceuticals, a division of Bausch Health US, LLC ($45.32).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Peter Seraphin

What kind of clinician is Dr. Peter Seraphin?

Dr. Peter Seraphin is listed as a physician specializing in gastroenterology.

Where does Dr. Peter Seraphin practice?

Hinsdale Gastroenterology Associates, Sc at 12 Salt Creek Ln, Suite 425, Hinsdale, IL 60521.

What is the office phone number for Dr. Peter Seraphin?

The listed office number is (630) 789-2260. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Peter Seraphin?

The National Provider Identifier is 1831204734.

Does Dr. Peter Seraphin accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Peter Seraphin affiliated with?

The University of Chicago Medical Center, Uchicago Medicine Adventhealth Bolingbrook, Uchicago Medicine Adventhealth Hinsdale, Uchicago Medicine Adventhealth la Grange.

Where did Dr. Peter Seraphin go to medical school?

Arizona College of Osteopathic Medicine Mid Western University, graduating in 2000.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2015-09-16
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare